INTERNATIONAL COMPARISON OF PHARMACEUTICAL EXPENDITURE IN MIDDLE INCOME COUNTRIES: METHODOLOGICAL QUESTIONS

被引：2
|
作者：
Kalo, Z. [1 ]
Inotai, A. [2 ]
Meresz, G. [2 ]
机构：
[1] Eotvos Lorand Univ, Budapest, Hungary
[2] Syreon Res Inst, Budapest, Hungary
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.120
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A21 / A21
页数：1
相关论文
共 50 条
  • [31] Uncovering the Hidden Burden of Pharmaceutical Poisoning in High-Income and Low-Middle-Income Countries: A Scoping Review
    Cowans, Claire
    Love, Anya
    Tangiisuran, Balamurugan
    Jacob, Sabrina Anne
    PHARMACY, 2023, 11 (06)
  • [32] Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
    Nebot Giralt, Ariadna
    Bourasseau, Anthony
    White, Gareth
    Pouget, Corinne
    Tabernero, Patricia
    Van Assche, Kerlijn
    Ravinetto, Raffaella
    BMJ GLOBAL HEALTH, 2020, 5 (10):
  • [33] Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey
    Fortunak, Joseph M.
    de Souza, Rodrigo O. M. A.
    Kulkarni, Amol A.
    King, Christopher L.
    Ellison, Tiffany
    Miranda, Leandro S. M.
    ANTIVIRAL THERAPY, 2014, 19 : 15 - 29
  • [34] Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries
    Tuan Anh Nguyen
    Knight, Rosemary
    Roughead, Elizabeth Ellen
    Brooks, Geoffrey
    Mant, Andrea
    HEALTH POLICY AND PLANNING, 2015, 30 (02) : 267 - 280
  • [35] Assessment tool for establishing local pharmaceutical manufacturing in low- and middle-income countries
    Zimmermann, Marita
    Adamson, Blythe
    Lam-Hine, Tracy
    Rennie, Timothy
    Stergachis, Andy
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2018, 26 (04) : 364 - 368
  • [36] The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries
    Son, Kyung-Bok
    Lee, Tae-Jin
    GLOBAL PUBLIC HEALTH, 2018, 13 (09) : 1169 - 1178
  • [37] EXCESSIVE EXPENDITURE OF INCOME ON TREATMENTS IN DEVELOPING-COUNTRIES
    HESKETH, T
    XING, ZW
    BRITISH MEDICAL JOURNAL, 1994, 309 (6966): : 1441 - 1441
  • [38] Public expenditure, income distribution, and growth in OECD countries
    Oscar Alfranca
    Miguel-Angel Galindo
    International Advances in Economic Research, 2003, 9 (2) : 133 - 139
  • [39] Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions?
    Adam, Taghreed
    Hsu, Justine
    de Savigny, Don
    Lavis, John N.
    Rottingen, John-Arne
    Bennett, Sara
    HEALTH POLICY AND PLANNING, 2012, 27 : 9 - 19
  • [40] Income class and pharmaceutical expenditure in Canada: 1964-1990
    Lexchin, J
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1996, 87 (01): : 46 - 50
12345